Drug giant Pfizer (NYSE: [[ticker:PFE]]) announced today that it is establishing an entrepreneurship partner network with academic medical research centers, called the Global Centers for Therapeutic Innovation, to be headquartered in Cambridge, MA. Yesterday Luke reported that UC San Francisco had inked a deal through the program, in which Pfizer could pay up to $85 million over five years to help get discoveries made at the school to market. The Global Centers program will first focus on U.S. institutions and later transition to also develop partnerships abroad, and will be led by Anthony Coyle, a former executive at AstraZeneca’s MedImmune Biologics division.
Author: Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
View all posts by Erin Kutz
